Alpha Tau Medical (NASDAQ:DRTS) & Envoy Medical (NASDAQ:COCH) Critical Comparison

Envoy Medical (NASDAQ:COCH) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Earnings and Valuation

This table compares Envoy Medical and Alpha Tau Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$234,000.00	228.67	-$23.76 million	($1.01)	-0.69
Alpha Tau Medical	N/A	N/A	-$42.63 million	($0.67)	-19.65

Envoy Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Envoy Medical and Alpha Tau Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Insider and Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 2.6% of Alpha Tau Medical shares are held by institutional investors. 7.1% of Envoy Medical shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Envoy Medical and Alpha Tau Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	1	0	2.00
Alpha Tau Medical	1	2	5	0	2.50

Envoy Medical presently has a consensus target price of $2.25, suggesting a potential upside of 223.28%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 4.29%. Given Envoy Medical’s higher probable upside, equities research analysts plainly believe Envoy Medical is more favorable than Alpha Tau Medical.

Summary

Envoy Medical beats Alpha Tau Medical on 7 of the 13 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.